Skip to main content
Jose (Toti) Sanchez Jr., MD, Preventive Medicine, Hollywood, FL

JoseL.(Toti)SanchezJr.MDMPH

Preventive Medicine • Hollywood, FL

Public Health & General Preventive Medicine

Past Deputy Chief, Armed Forces Health Surveillance Division (AFHSD), Public Health Division, Defense Health Agency (DHA)

Join to view full profile

Dr. Sanchez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sanchez's full profile

Already have an account?

  • Office

    2301 South Ocean Drive
    Unit 601
    Hollywood, FL 33019
    Phone+1 240-660-0488
    Fax+1 301-319-7620

Summary

  • Dr. Sanchez is a graduate of University of Puerto Rico’s School of Medicine in 1979. He completed an Internal Medicine internship & post-graduate training at Johns Hopkins University & Walter Reed Army Institute of Research from 1979-1983. For over 40 years he has specialized in infectious disease epidemiology, outbreak investigation & research with over 180 publications & 300+ presentations

Education & Training

  • Walter Reed Army Institute of Research
    Walter Reed Army Institute of ResearchMD, 1981 - 1983
  • Johns Hopkins University School of Hygiene & Public Health
    Johns Hopkins University School of Hygiene & Public HealthMPH, Epidemiology, Cum Laude, 1980 - 1981
  • William Beaumont Army Medical Center
    William Beaumont Army Medical CenterInternship, Internal Medicine, 1979 - 1980
  • University of Puerto Rico School of Medicine
    University of Puerto Rico School of MedicineClass of 1979
  • University of Puerto Rico
    University of Puerto RicoBS, 1972 - 1975
  • University of Puerto Rico
    University of Puerto RicoBS, Biology, Cum Laude, 1972 - 1975

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1981 - 2021
  • FL State Medical License
    FL State Medical License 2001 - 2020
  • American Board of Preventive Medicine Public Health & General Preventive Medicine

Publications & Presentations

PubMed

Journal Articles

  • Seroprevalence as an Indicator of Undercounting of COVID-19 Cases in a Large, Well-described Cohort  
    Taylor KM, Ricks KM, Kuehnert PA, Eick-Cost AA, Scheckelhoff MR, Wiesen AR, Clements TL, Hu Z, Zak SE, Olschner SP, Herbert AS, Bazaco SL, Creppage KE, Fan MT, Sanchez JL, Am J Prev Med Focus, 8/15/2023
  • Military participation in health security: analysis of Joint External Evaluation Reports and National Action Plans for Health Security  
    Forshey BM, Woodward A, Sanchez JL, Petzing SR, Health Security, 2/15/2021
  • Neutralizing and neuraminidase antibodies correlate with protection against influenza during a late season A/H3N2 outbreak among unvaccinated military recruits  
    Weiss CD, Wang W, Lu Y, Billings M, Eick-Cost A, Couzens L, Sanchez JL, Hawksworth AW, Seguin P, Myers CA, Forshee R, Eichelberger MC, Cooper MJ, Clinical Infectious Diseases, 12/16/2019
  • Join now to see all

Books/Book Chapters

  • Acute Respiratory Infections in Training & Mobilization, Occupational Health and the Warfighter 
    Chapter: Acute Respiratory Infections in Training and Mobilization: Past Experience and Approached for their Control 
    Sanchez JL, Cooper MJ, Jones FR, Vest KG, Russell KL, Sanchez JL, Hiser MJ, Gaydos CAEditors: Office of The Army Surgeon General.Borden Institute, Washington, DCEdition 1,2021
  • Shigellosis and Cholera in Textbook of Military Medicine: Mobilization & Deployment 
    Chapter: Shigellosis and Cholera. Diseases spread by food, water, and soil. Military Preventive Medicine: Mobilization and Deployment 
    Page 1025 - 1038Sanchez JLUS Army Surgeon General and the Borden Institute, Washington, DC2005
  • Diarrheal Diseases in Textbook of Military Medicine: Mobilization & Deployment 
    Chapter: Chapter 37: Diseases transmitted by food, water, and soil 
    Page 1025 - 1038Taylor DN, Ludwig SL, Binn LN, Fleckenstein J, Sanchez JL, Petri WA, Schaenman JM, Hoge CW, Cross JH, Patrick W, Aronson NE, Hospenthal DR, Lee M-A, Yap EPHUS Army Surgeon General and the Borden Institute, Washington, DC2005
  • Join now to see all

Abstracts/Posters

  • Human Sera Drives Quasispecies Composition of Influenza B Viruses Grown in Vitro
    Plant EP, Manukyan H, Sanchez JL, Laassri M, Ye Z, American Society for Virology 39th annual meeting, Colorado State University, Fort Collins, CO, 6/13/2020
  • El Niño-Southern Oscillation Teleconnections and Global Patterns of Disease Outbreaks
    Soebiyanto RP, Anyamba A, Hutchinson S, Small JL, Damoah R, Forshey B, Toolin CF, Britch SC, Tucker CJ, Karesh W, Thiaw WM, Chretien J-P, Sanchez JL, Linthicum KJ, American Geophysical Union (AGU) Fall Meeting, San Francisco, CA, 12/13/2019
  • El Niño-Southern Oscillation Teleconnections and Global Patterns of Disease Outbreaks
    Soebiyanto RP, Anyamba A, Hutchinson S, Small JL, Damoah R, Forshey B, Toolin CF, Britch SC, Tucker CJ, Karesh W, Thiaw WM, Chretien J-P, Sanchez JL, Linthicum KJ, American Geophysical Union (AGU) Fall Meeting, San Francisco, CA, 12/11/2019
  • Join now to see all

Lectures

  • COVID-19 & Influenza: Impact on Global Public Health 
    Principles & Practice of Tropical Medicine Course, USU, Bethesda, MD - 3/3/2021
  • COVID-19: An Update 
    Infectious Disease Epidemiology Course, USU, Bethesda, MD - 2/5/2021
  • Influenza: An Update 
    Infectious Disease Epidemiology Course, USU, Bethesda, MD - 2/3/2021
  • Join now to see all

Other

Grant Support

  • New tools for antigenic analysis of influenza viruses, 2018AFHSB-GEIS, Defense Health Agency (DHA)2018
  • Evaluation of Influenza Vaccination Correlates of ProtectionAFHSB-GEIS, Defense Health Agency (DHA)2018
  • Assessing the correlation between neutralizing and/or neuraminidase inhibiting (NAI) antibody titers and protection against influenza infection and disease, 2016-2018AFHSB-GEIS, Defense Health Agency (DHA)2017–2018
  • Retrospective, 10-year Epidemiologic Assessment of the Association of Bacterial Vaginosis with Chlamydia trachomatis and Neisseria gonorrhoeae infections and subsequent Pelvic Inflammatory Disease (PID) Risk among U.S. Army Active Duty Military Personnel, 2003-2012Armed Forces Health Surveillance Center (AFHSC)2014–2017
  • “Estimating Gonorrea Resistance and Risk Factors among Symptomatic Military Men and Women at select CONUS Sites and comparing them to OCONUS Data”Armed Forces Health Surveillance Center (AFHSC)2011–2017
  • “Retrospective, 12-year Seroepidemiologic Modelling & Assessment of Respiratory/Influenza Severity in the US military, 2000-2012”Armed Forces Health Surveillance Center (AFHSC)2012–2014
  • “Seroepidemiology of HPV, HSV and Syphilis among Active Duty US Military Service Members serving in the Army, Navy, Air Force or Marines”Armed Forces Health Surveillance Center (AFHSC)2011–2013
  • “Comprehensive International Program of Research on AIDS/HIV (CIPRA)”National Institutes of Allergy & Infectious Diseases (NIAID)2003–2008
  • “Targeted Surveillance and Genetic Analysis”Walter Reed Army Institute of Research (WRAIR)2003–2008
  • “President’s Emergency Plan on HIV/AIDS in Africa (“PEPFAR” or Emergency Plan)”Walter Reed Army Institute of Research (WRAIR)2005–2006
  • “HIV Vaccine Trials Unit (HVTU)-Core”National Institutes of Allergy & Infectious Diseases (NIAID)2001–2005
  • “HIV Prevention Trials Unit (HPTU)-Core”National Institutes of Allergy & Infectious Diseases (NIAID)2001–2005
  • “A phase 1 study of the safety and immunogenicity of E.coli-derived recombinant Protective Antigen (rPA), a new anthrax vaccine administered by the intramuscular (IM) route in healthy adults”DynPort Vaccine Company LLC, Frederick, MD2003–2004
  • “Surveillance for HIV-1 genetic subtypes and recombinant forms in Latin America”Walter Reed Army Institute of Research (WRAIR)2002–2003
  • “Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety and tolerability of two yellow fever 17D vaccines (ARILVAX™ and YF-VAX™) in healthy infants and children in Peru”Acambis, Inc.2001–2003
  • “HIV Pathogenesis, Research and Treatment in the Andes”National Institutes of Allergy & Infectious Diseases (NIAID)2001–2003
  • “Seroincidence and subtyping of HIV-1 in a cohort of men who have sex with men and commercial sex workers in Buenos Aires, Argentina”Walter Reed Army Institute of Research (WRAIR)2001–2002
  • “Surveillance of HIV-1 in Central America”Walter Reed Army Institute of Research (WRAIR)2001–2002
  • “Surveillance of HIV-1 in South America”Walter Reed Army Institute of Research (WRAIR)2001–2002
  • “Epidemiology of HIV-1 Isolates in Argentina and Uruguay”Walter Reed Army Institute of Research (WRAIR)2000–2001
  • “Prevalence, Incidence and Risk Factors for HIV Infection among Men who have Sex with Men in the city of Lima”Walter Reed Army Institute of Research (WRAIR)2000–2001
  • “Epidemiology of HIV-1 Isolates in South America”Walter Reed Army Institute of Research (WRAIR)2000–2001
  • Protocol, ““Double-Blind, Placebo-Controlled Clinical Efficacy Trial of Pneumococcal Vaccine or Benzathin Penicillin G (BPG) as Prophylaxis Against Bacterial Agents Causing Febrile Acute Respiratory Disease Among Ranger Trainees”US Center for Health Promotion and Preventive Medicine (USACHPPM)1999–2000
  • Protocol, “Randomized, double-blind, phase III, placebo-controlled trial of the protective efficacy of the oral whole cell plus recombinant B subunit (WC/rBS) cholera vaccine in Peru”US Army Medical Materiel & Development Agency (USAMMDA)1993–1996

Committees

  • DSMB Member, Data Safety Monitoring Board (DSMB), Protocol MV-CHIK-206 – A Phase 2 Study of a Live, Attenuated Measles Virus-Vectored Chikungunya Vaccine in Previously Exposed Adults 2019 - 2021
  • Member, Operational Steering Committee (OSC), Infectious Disease Clinical Research Program (IDCRP) 2016 - 2021
  • Member, Safety Review Committee (SRC), Protocol DR-501-402 – Sentinel Surveillance Plan for Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, INC Research & Teva Pharmaceuticals USA, Inc. & MILVAX 2012 - 2015

Other Languages

  • Portuguese

Dr. Jose Sanchez, Dr. Jose Sanchez, MD, Dr. J Sanchez, Dr. Jose L. Sanchez